We are proud to announce that Innovative Medicines Group (IMG) has been appointed as the exclusive representative of the World Orphan Drug Alliance (WODA) in Latin America.WODA is a global network of pharmaceutical distributors specializing in orphan drugs and rare disease therapies. The alliance is committed to ensuring patient access to essential treatments, even in complex or underserved markets.
What does this alliance mean for IMG?
It strengthens our position as a regional leader in the field of rare diseases.
It allows us to expand our therapeutic portfolio to address a wider range of rare conditions.
It enhances our ability to partner with pharmaceutical and biotech companies to bring specialized therapies to the region.
With IMG’s inclusion, WODA now spans 158 countries, reaching over 210 million rare disease patients globally.
This milestone underscores our long-standing commitment to expanding access to treatments across key Latin American markets, including Brazil, Argentina, Colombia, and Mexico.
About WODA
The World Orphan Drug Alliance provides end-to-end support for the commercialization and distribution of orphan and specialty medicines, ensuring availability in some of the world’s most challenging markets.
📎 Learn more at: www.woda-alliance.com
Through this alliance, we reaffirm our commitment to global health and equitable access to rare disease treatments across Latin America.
#InnovativeMedicinesGroup #WODA #RareDiseases #GlobalHealth #OrphanDrugs #StrategicPartnerships